German pharmaceutical company BioNTech has agreed to pay a combined sum of more than $1.2 billion to resolve separate disputes over royalty payments related to its COVID-19 vaccine.
Source
Deutsche Welle
COVID: BioNTech to pay $1.2 billion over vaccine royalties
28
Dec
Dec
Source